CAPR
Advertising Networks · United Kingdom · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Whitegates Dalwood, Axminster, Devon, EX...Phone Number
+44 2087474658Website
www.capstrategicresearch.comRevenue
<$5 MillionIndustry
About CAPR
CAPR Org Chart
Is CAPR your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if CAPR has recently received funding, and reach out quickly before it becomes old news!
Check out if CAPR is spiking on competitors!
Earning: See what the market has to say on CAPR recently announced quarterly report
Click to see if CAPR had a recent Job posting/layoffs
CAPR, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once CAPR has new funding data
Congratulate Masked Content for being promoted to Masked Content at CAPR
Product Launch: Get notified when CAPR launches new products
Recommended Actions
Reach out to Masked Content who joined CAPR as Masked Content
Find 2 more new buyers
Compare Similar Companies to CAPR
Compare insights from companies similar to CAPR, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
CAPR is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
CAPR is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about CAPR.
CAPR Tech Stack
A closer look at the technologies used by CAPR
CAPR News & Media
Deadline Alert: Capricor Therapeutics, Inc. (CAPR) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
LOS ANGELES, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming September 28, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) securities between December 17, 2025 and July 26, 2026 inclusive (the “Class Period”).CAPR Investor Alert: Capricor Therapeutics, Inc. Securities Class Action Notice - Contact Levi & Korsinsky
Capricor Therapeutics shareholders who purchased between December 17, 2025 and July 26, 2026 retain specific rights under federal securities law, including the ability to seek recovery of losses tied to an alleged $15.08 per-share decline following FDA briefing documents on the HOPE-3 trial. Capricor Therapeutics shareholders who purchased between December 17, 2025 and July 26, 2026 retain specific rights under federal securities law, including the ability to seek recovery of losses tied to an aCapricor Therapeutics, Inc. (CAPR) Q2 2026 Earnings Call Prepared Remarks Transcript
Capricor Therapeutics, Inc. (CAPR) Q2 2026 Earnings Call August 13, 2026 4:30 PM EDTCompany ParticipantsAnthony Bergmann - CFO & Corporate...CAPR Shareholder Alert: Capricor Therapeutics, Inc. Securities Class Action Lawsuit - Investors Should Contact SueWallSt
A securities class action alleges Capricor Therapeutics told investors its Deramiocel application was progressing toward an August 22, 2026 PDUFA date while allegedly omitting that the final statistical analysis plan governing HOPE-3 was never submitted to or agreed upon by the FDA before the BLA resubmission A securities class action alleges Capricor Therapeutics told investors its Deramiocel application was progressing toward an August 22, 2026 PDUFA date while allegedly omitting that the fina
Top Advertising Networks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CAPR
CAP Strategic Research provides market research services across China, Hong Kong, Singapore, and other Asia-Pacific countries. The company leverages extensive industry experience and in-depth knowledge to deliver strategic insights and actionable recommendations. Their target clients include senior executives from various sectors such as banking, h... Read More